Document is current
Any future updates will be listed below
-
Authors
Bartelo, Nicholas
Li, Yaxin
Hao, Ying
Soni, Vijay
Marino, Jamie
Yang, He S.
Satlin, Michael J.
Wang, Fei
Krumsiek, Jan
Zhao, Zhen
-
Funding
Funding for this research was provided by:
Waters Corporation (Seed instument)
- License Information
-
More Information
Article History
Received: 16 May 2025
Accepted: 11 May 2026
First Online: 26 May 2026
Competing interests
: J.K. is co-founder and holds equity in iollo and ExactRx (Celeste Health, Inc) and is an advisor to Everfur (Strand Health, Inc) but declares no non-financial competing interests. M.J.S. previously acted as a paid consultant for Shionogi and has received research funding from Merck, SNIPRBiome, bioMéreiux, and Selux Diagnostics, but declares no non-financial competing interests. Z.Z. previously acted as a paid consultant/advisor for ET Healthcare, Radiometer, Intelligenome, Roche and Siemens and has received sponsored research/seed instrument from Roche, Siemens, ET Healthcare, Gator Bio, Novartis, Polymedco, and Waters, but declares no non-financial competing interests. H.S.Y., F.W., N.B., Y.L., Y.H., V.S., and J.M. declare no financial or non-financial competing interests.
